CPIM
PBYI icon

Columbia Partners Investment Management’s Puma Biotechnology PBYI Stock Holding History

Columbia Partners Investment Management’s Portfolio PBYI Stock Details PBYI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q4 		– Sell
-44,539
Closed -$2.99M – 304
2016
Q3 		$2.99M Buy
+44,539
New +$2.25M 0.23% 144

Other funds holding PBYI

Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
O
OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return
JHIU
Janus Henderson Investors US Denver, Colorado $122B AUM 18.26% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.49B AUM 208.7% 1-Year Est. Return
PHS
PFM Health Sciences San Francisco, California $1.17B AUM 92.19% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return

Columbia Partners Investment Management's PBYI Position: Q4 2016 in Review

Columbia Partners Investment Management sold out of Puma Biotechnology (PBYI) in Q4 2016, closing a stake of 44,539 shares — an estimated $2.99M sold.

Columbia Partners Investment Management first reported a position in PBYI in Q3 2016 and held it in 1 quarter. The position peaked at $2.99M in Q3 2016. 128 funds tracked by Wall St. Rank hold PBYI as of Q4 2016.

  • Columbia Partners Investment Management reported no remaining Puma Biotechnology position as of Q4 2016 after selling out during the quarter.
  • Columbia Partners Investment Management sold 44,539 Puma Biotechnology shares in Q4 2016, an estimated $2.99M.
  • Columbia Partners Investment Management first reported a position in Puma Biotechnology in Q3 2016 and held it in 1 quarter.
  • Columbia Partners Investment Management's Puma Biotechnology position peaked at $2.99M in Q3 2016.
  • 128 funds tracked by Wall St. Rank held Puma Biotechnology as of Q4 2016.

Based on Columbia Partners Investment Management's 13F filing for Q4 2016, filed 13 Feb 2017.